銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

Shilpa Medicare
SHILPAMED ?NSE

Shilpa Medicare

?556.9011.30 (2.07%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
542.05
Today’s high
558.85
52 week low
259.50
52 week high
589.00
Open price
545.60
Previous close
545.60
Live volume
2,42,530
Lower circuit
436.50
Upper circuit
654.70

Fundamentals

Market Cap
?10,674Cr
ROE
9.39%
P/E Ratio(TTM)
43.87
EPS(TTM)
12.44
P/B Ratio
4.12
Dividend Yield
0.11%
Industry P/E
33.86
Book Value
132.49
Debt to Equity
0.25
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
?439
+6.85%
Profit (Cr)
?108
+141.79%
0150300450600
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+30%
3Y CAGR+4%
Profit growthValue
1Y (TTM)+643%
3Y CAGR+9%

About

Starting its journey in 1987, Shilpa Medicare Limited has grown into a well-regarded manufacturer of Active Pharmaceutical Ingredients (APIs) and other medical formulations. The company firmly believes that every person in the world deserves the right to have access to high-quality and affordable healthcare services and products. A core principle that guides all its business activities is the commitment to maintaining the highest possible ethical standards in everything the company does. It serves customers worldwide by providing a broad selection of products, including oncology and non-oncology APIs, specialized formulations, and advanced biosimilars. Through consistent investment in research and development, the organization works towards creating and supplying innovative new solutions to meet various healthcare needs. The company has established a strong leadership position in the cancer-drug segment, securing almost 30% of the worldwide market for top oncology medicines.;
CEO/MD
Mr. Vishnukant Chaturbhuj Bhutada
Founded in
1987
NSE symbol
SHILPAMED

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
40.21%
Promoters
40.13%
Foreign Institutions
11.08%
Mutual Funds
5.15%
Other Domestic Institutions
3.43%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
?8,404.50
-124.50 (1.46%)
L
    H
    21,286.25113.5124.39
    PfizerPFIZER
    ?4,528.10
    -11.20 (0.25%)
    L
      H
      20,766.7328.744.94
      ?1,452.00
      +21.40 (1.50%)
      L
        H
        19,822.7430.615.08
        ?785.15
        +3.05 (0.39%)
        L
          H
          19,386.3932.583.81
          Livesquawk ?
          Shilpa Medicare partners with Gate2Brain for 30.4% stake to enhance brain cancer treatment. G2B-002 targets orphan drug status from US FDA and EMA under the strategic partnership.
          Livesquawk ?
          Shilpa Medicare's albumin Phase 3 plan gets CDSCO approval. IMPD submission to EMA targeted by Shilpa in H1 FY27.
          Livesquawk ?
          Shilpa Medicare completes lab development for teduglutide. Process validation batches are expected by H1 FY27.
          Livesquawk ?
          Shilpa Medicare plans to expand its Onco Block, targeting FY27 completion. The expansion aims to facilitate the launch of new oncology products.
          2026
          22
          May
          Quarterly & Annual Result
          Release date
          6
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date

          3
          Oct
          Bonus
          Ex date
          1:1
          Ratio

          For every 1 shares you hold, you will receive 1 additional shares
          Bonus ratio1:1
          Ex date3 Oct ‘25
          Record date3 Oct ‘25
          Announcement date18 Sep ‘25

          18
          Sep
          Bonus
          Announced
          1:1
          Ratio

          For every 1 shares you hold, you will receive 1 additional shares
          Bonus ratio1:1
          Ex date3 Oct ‘25
          Record date3 Oct ‘25
          Announcement date18 Sep ‘25

          17
          Sep
          Dividend
          Ex date
          ?1.00
          per share

          For each share you hold, you will receive ?1.00
          Dividend amount?1.00 per share
          Dividend TypeFinal
          Ex Date17 Sep ‘25
          Record Date17 Sep ‘25
          Announcement date26 May ‘25
          13
          Aug
          Quarterly Result
          Release date

          26
          May
          Dividend
          Announced
          ?1.00
          per share

          For each share you hold, you will receive ?1.00
          Dividend amount?1.00 per share
          Dividend TypeFinal
          Ex Date17 Sep ‘25
          Record Date17 Sep ‘25
          Announcement date26 May ‘25
          Events calendar
          View upcoming events in other stocks

          銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

          xxfseo.com